Shuttle Pharmaceuticals Elects New Directors, Reports Other Events
Ticker: SHPH · Form: 8-K · Filed: Jun 18, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $227,000, $72,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, corporate-governance
TL;DR
Shuttle Pharma adds 2 directors, updates exec pay, and files other docs.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. announced on June 13, 2024, a series of significant corporate actions. These include the election of two new directors, Dr. David J. Ebersole and Mr. David L. Messner, to its Board of Directors, effective immediately. The company also disclosed compensatory arrangements for its named executive officers and reported other events, though specific details on these arrangements and events were not provided in this excerpt.
Why It Matters
The addition of new directors can signal a shift in strategy or governance for the company, potentially impacting its future direction and shareholder value.
Risk Assessment
Risk Level: medium — The filing indicates changes in board composition and executive compensation, which can introduce uncertainty or signal strategic shifts.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- Dr. David J. Ebersole (person) — Newly elected Director
- Mr. David L. Messner (person) — Newly elected Director
- June 13, 2024 (date) — Date of earliest event reported
FAQ
Who are the newly elected directors of Shuttle Pharmaceuticals Holdings, Inc.?
Dr. David J. Ebersole and Mr. David L. Messner were elected as directors.
When were the new directors elected?
The election of the new directors was effective as of June 13, 2024.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The address is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the fiscal year end for Shuttle Pharmaceuticals Holdings, Inc.?
The fiscal year end is December 31.
Filing Stats: 914 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2024-06-18 09:00:15
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
- $227,000 — r. Lorber will receive a base salary of $227,000 per annum, a grant of 227,635 restricte
- $72,000 — , and will be eligible to receive up to $72,000 as a milestone-based bonus. In addition
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex10-1.htm (EX-10.1) — 151KB
- ex99-1.htm (EX-99.1) — 13KB
- 0001493152-24-024224.txt ( ) — 414KB
- shph-20240613.xsd (EX-101.SCH) — 3KB
- shph-20240613_lab.xml (EX-101.LAB) — 33KB
- shph-20240613_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: June 18, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer